Wealth Enhancement Advisory Services
TMO icon

Wealth Enhancement Advisory Services’s Thermo Fisher Scientific TMO Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$28.2M Buy
93,673
+3,098
+3% +$1.49M 0.05% 339
2026
Q1 		$25.6M Sell
90,575
-42,770
-32% -$23.2M 0.05% 317
2025
Q4 		$83.3M Buy
133,345
+1,724
+1% +$975K 0.11% 171
2025
Q3 		$71M Buy
131,621
+213
+0.2% +$99.1K 0.11% 177
2025
Q2 		$56.4M Buy
131,408
+4,258
+3% +$1.78M 0.09% 207
2025
Q1 		$63.3M Sell
127,150
-122
-0.1% -$66.1K 0.12% 166
2024
Q4 		$66.2M Buy
127,272
+1,556
+1% +$855K 0.13% 157
2024
Q3 		$77.8M Buy
125,716
+656
+0.5% +$388K 0.17% 123
2024
Q2 		$69.2M Sell
125,060
-528
-0.4% -$302K 0.16% 128
2024
Q1 		$73M Sell
125,588
-869
-0.7% -$488K 0.19% 113
2023
Q4 		$67.1M Buy
126,457
+1,378
+1% +$667K 0.2% 117
2023
Q3 		$63.3M Buy
125,079
+123,379
+7,258% +$65.7M 0.21% 109
2023
Q2 		$887K Buy
1,700
+130
+8% +$70.2K 0.01% 277
2023
Q1 		$905K Buy
+1,570
New +$885K 0.01% 315
2022
Q4 		– Sell
-11,048
Closed -$5.78M – 366
2022
Q3 		$5.78M Buy
+11,048
New +$6.18M 0.08% 113
2021
Q3 		– Sell
-7,866
Closed -$4.05M – 339
2021
Q2 		$4.05M Buy
7,866
+5,676
+259% +$2.68M 0.07% 113
2021
Q1 		$1.03M Buy
2,190
+182
+9% +$86.9K 0.02% 196
2020
Q4 		$1.01M Buy
+2,008
New +$942K 0.02% 167
2019
Q3 		– Sell
-6,113
Closed -$1.77M – 240
2019
Q2 		$1.77M Buy
+6,113
New +$1.68M 0.08% 105

Other funds holding TMO

Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
LT
Lindsell Train London, United Kingdom $2.63B AUM 2.97% 1-Year Est. Return
ATO
Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Wealth Enhancement Advisory Services's TMO Position: Q2 2026 in Review

Wealth Enhancement Advisory Services increased its Thermo Fisher Scientific (TMO) stake by 3.4% in Q2 2026, buying an estimated $1.49M and bringing the position to 93,673 shares worth $28.2M. The position accounts for 0.05% of the portfolio, ranked #339.

Wealth Enhancement Advisory Services first reported a position in TMO in Q2 2019 and has held it in 19 quarters since. The position peaked at $83.3M in Q4 2025. 708 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Wealth Enhancement Advisory Services held 93,673 shares of Thermo Fisher Scientific worth $28.2M as of Q2 2026.
  • Wealth Enhancement Advisory Services bought 3,098 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.49M.
  • Thermo Fisher Scientific made up 0.05% of Wealth Enhancement Advisory Services's portfolio in Q2 2026, its #339 holding.
  • Wealth Enhancement Advisory Services first reported a position in Thermo Fisher Scientific in Q2 2019 and has held it in 19 quarters since.
  • Wealth Enhancement Advisory Services's Thermo Fisher Scientific position peaked at $83.3M in Q4 2025.
  • 708 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.